Scrapping Its IPO, Phenomix Teams Up With Forest

The deal funds ongoing clinical development of dutogliptin and provides a cushion in difficult financial times.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet